Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Spectrum of Functional, Structural and Patient-Reported Outcomes in Intermediate Age-Related Macular Degeneration - A MACUSTAR Study Report.
Terheyden JH, Holz FG, Behning C, Dunbar HMP, Schmitz-Valckenberg S, Tufail A, Schmid M, Crabb DP, Saßmannshausen M, Binns A, Hoyng CB, Zakaria N, Poor S, Moll KP, Cosette D, Martinho C, Batuca J, Cunha-Vaz J, Luhmann UFO, Leal S, Finger RP; MACUSTAR consortium. Terheyden JH, et al. Among authors: crabb dp. Ophthalmologica. 2025 Feb 3:1-19. doi: 10.1159/000543231. Online ahead of print. Ophthalmologica. 2025. PMID: 39900013 Free article.
Are Patient Self-Reported Outcome Measures Sensitive Enough to Be Used as End Points in Clinical Trials?: Evidence from the United Kingdom Glaucoma Treatment Study.
Jones L, Garway-Heath DF, Azuara-Blanco A, Crabb DP; United Kingdom Glaucoma Treatment Study Investigators. Jones L, et al. Among authors: crabb dp. Ophthalmology. 2019 May;126(5):682-689. doi: 10.1016/j.ophtha.2018.09.034. Epub 2018 Sep 28. Ophthalmology. 2019. PMID: 30273622 Clinical Trial.
Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting-lessons from the MACUSTAR study.
Terheyden JH, Dunbar HMP, Schmitz-Valckenberg S, Behning C, Martinho C, Luhmann UFO, Saßmannshausen M, Lüning A, Miliu A, Aires ID, Basile PG, Batuca J, Schmid M, Moll KP, Zakaria N, Tufail A, Binns A, Crabb DP, Leal S, Finger RP, Holz FG; MACUSTAR consortium. Terheyden JH, et al. Among authors: crabb dp. Eye (Lond). 2025 Feb 5. doi: 10.1038/s41433-024-03568-2. Online ahead of print. Eye (Lond). 2025. PMID: 39910281 Review.
Validating and Updating the OHTS-EGPS Model Predicting 5-year Glaucoma Risk among Ocular Hypertension Patients Using Electronic Records.
Wright DM, Azuara-Blanco A, Cardwell C, Montesano G, Crabb DP, Gazzard G, King AJ, Hernández R, Morgan JE, Higgins B, Takwoingi Y; GRIP study group. Wright DM, et al. Among authors: crabb dp. Ophthalmol Glaucoma. 2024 Nov 4:S2589-4196(24)00187-X. doi: 10.1016/j.ogla.2024.10.009. Online ahead of print. Ophthalmol Glaucoma. 2024. PMID: 39505150 Free article.
243 results